Covid-19 Vaccine Industry Research Report 2023
This report aims to provide a comprehensive presentation of the global market for Covid-19 Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Covid-19 Vaccine.
The Covid-19 Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Covid-19 Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by Covid-19 Vaccine type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Covid-19 Vaccine are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Covid-19 Vaccine segment by Type
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Covid-19 Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Covid-19 Vaccine market.
Covid-19 Vaccine Segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Covid-19 Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Covid-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Covid-19 Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Covid-19 Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
The Covid-19 Vaccine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Covid-19 Vaccine market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Covid-19 Vaccine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- Moderna
- CanSino Biologicals
- Inovio Pharmaceuticals
- Shenzhen Geno-Immune Medical Institute
- GlaxoSmithKine
- Pfizer
- Johnson?Johnson
- Heat Biologics
- Sanofi
Global markets are presented by Covid-19 Vaccine type, along with growth forecasts through 2029. Estimates on revenue are based on the price in the supply chain at which the Covid-19 Vaccine are procured by the companies.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
Covid-19 Vaccine segment by Type
- DNA
- Non-replicating Viral Vector
- Protein Subunit
- RNA
- Others
This report has provided the market size (revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the Covid-19 Vaccine market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Covid-19 Vaccine market.
Covid-19 Vaccine Segment by Application
- Adults
- Children
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast revenue for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Covid-19 Vaccine market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Covid-19 Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Covid-19 Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Covid-19 Vaccine industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Covid-19 Vaccine.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Covid-19 Vaccine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Covid-19 Vaccine by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
2.3 Covid-19 Vaccine by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Adults
2.3.3 Children
2.4 Assumptions and Limitations
3 COVID-19 VACCINE BREAKDOWN DATA BY TYPE
3.1 Global Covid-19 Vaccine Historic Market Size by Type (2018-2023)
3.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2023-2028)
4 COVID-19 VACCINE BREAKDOWN DATA BY APPLICATION
4.1 Global Covid-19 Vaccine Historic Market Size by Application (2018-2023)
4.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Covid-19 Vaccine Market Perspective (2018-2029)
5.2 Global Covid-19 Vaccine Growth Trends by Region
5.2.1 Global Covid-19 Vaccine Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Covid-19 Vaccine Historic Market Size by Region (2018-2023)
5.2.3 Covid-19 Vaccine Forecasted Market Size by Region (2024-2029)
5.3 Covid-19 Vaccine Market Dynamics
5.3.1 Covid-19 Vaccine Industry Trends
5.3.2 Covid-19 Vaccine Market Drivers
5.3.3 Covid-19 Vaccine Market Challenges
5.3.4 Covid-19 Vaccine Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Covid-19 Vaccine Players by Revenue
6.1.1 Global Top Covid-19 Vaccine Players by Revenue (2018-2023)
6.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2018-2023)
6.2 Global Covid-19 Vaccine Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Covid-19 Vaccine Head office and Area Served
6.4 Global Covid-19 Vaccine Players, Product Type & Application
6.5 Global Covid-19 Vaccine Players, Date of Enter into This Industry
6.6 Global Covid-19 Vaccine Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Covid-19 Vaccine Market Size (2018-2029)
7.2 North America Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Covid-19 Vaccine Market Size by Country (2018-2023)
7.4 North America Covid-19 Vaccine Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Covid-19 Vaccine Market Size (2018-2029)
8.2 Europe Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Covid-19 Vaccine Market Size by Country (2018-2023)
8.4 Europe Covid-19 Vaccine Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Covid-19 Vaccine Market Size (2018-2029)
9.2 Asia-Pacific Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Covid-19 Vaccine Market Size by Country (2018-2023)
9.4 Asia-Pacific Covid-19 Vaccine Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Covid-19 Vaccine Market Size (2018-2029)
10.2 Latin America Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Covid-19 Vaccine Market Size by Country (2018-2023)
10.4 Latin America Covid-19 Vaccine Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Covid-19 Vaccine Market Size (2018-2029)
11.2 Middle East & Africa Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Covid-19 Vaccine Market Size by Country (2018-2023)
11.4 Middle East & Africa Covid-19 Vaccine Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Moderna
11.1.1 Moderna Company Detail
11.1.2 Moderna Business Overview
11.1.3 Moderna Covid-19 Vaccine Introduction
11.1.4 Moderna Revenue in Covid-19 Vaccine Business (2017-2022)
11.1.5 Moderna Recent Development
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Detail
11.2.2 CanSino Biologicals Business Overview
11.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
11.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2017-2022)
11.2.5 CanSino Biologicals Recent Development
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Detail
11.3.2 Inovio Pharmaceuticals Business Overview
11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
11.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2017-2022)
11.3.5 Inovio Pharmaceuticals Recent Development
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Detail
11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
11.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2017-2022)
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Detail
11.5.2 GlaxoSmithKine Business Overview
11.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
11.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2017-2022)
11.5.5 GlaxoSmithKine Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Covid-19 Vaccine Introduction
11.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2017-2022)
11.6.5 Pfizer Recent Development
11.7 Johnson?Johnson
11.7.1 Johnson?Johnson Company Detail
11.7.2 Johnson?Johnson Business Overview
11.7.3 Johnson?Johnson Covid-19 Vaccine Introduction
11.7.4 Johnson?Johnson Revenue in Covid-19 Vaccine Business (2017-2022)
11.7.5 Johnson?Johnson Recent Development
11.8 Heat Biologics
11.8.1 Heat Biologics Company Detail
11.8.2 Heat Biologics Business Overview
11.8.3 Heat Biologics Covid-19 Vaccine Introduction
11.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2017-2022)
11.8.5 Heat Biologics Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Covid-19 Vaccine Introduction
11.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2017-2022)
11.9.5 Sanofi Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 Covid-19 Vaccine by Type
2.2.1 Market Value Comparison by Type (2018 VS 2022 VS 2029)
1.2.2 DNA
1.2.3 Non-replicating Viral Vector
1.2.4 Protein Subunit
1.2.5 RNA
1.2.6 Others
2.3 Covid-19 Vaccine by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029)
2.3.2 Adults
2.3.3 Children
2.4 Assumptions and Limitations
3 COVID-19 VACCINE BREAKDOWN DATA BY TYPE
3.1 Global Covid-19 Vaccine Historic Market Size by Type (2018-2023)
3.2 Global Covid-19 Vaccine Forecasted Market Size by Type (2023-2028)
4 COVID-19 VACCINE BREAKDOWN DATA BY APPLICATION
4.1 Global Covid-19 Vaccine Historic Market Size by Application (2018-2023)
4.2 Global Covid-19 Vaccine Forecasted Market Size by Application (2018-2023)
5 GLOBAL GROWTH TRENDS
5.1 Global Covid-19 Vaccine Market Perspective (2018-2029)
5.2 Global Covid-19 Vaccine Growth Trends by Region
5.2.1 Global Covid-19 Vaccine Market Size by Region: 2018 VS 2022 VS 2029
5.2.2 Covid-19 Vaccine Historic Market Size by Region (2018-2023)
5.2.3 Covid-19 Vaccine Forecasted Market Size by Region (2024-2029)
5.3 Covid-19 Vaccine Market Dynamics
5.3.1 Covid-19 Vaccine Industry Trends
5.3.2 Covid-19 Vaccine Market Drivers
5.3.3 Covid-19 Vaccine Market Challenges
5.3.4 Covid-19 Vaccine Market Restraints
6 MARKET COMPETITIVE LANDSCAPE BY PLAYERS
6.1 Global Top Covid-19 Vaccine Players by Revenue
6.1.1 Global Top Covid-19 Vaccine Players by Revenue (2018-2023)
6.1.2 Global Covid-19 Vaccine Revenue Market Share by Players (2018-2023)
6.2 Global Covid-19 Vaccine Industry Players Ranking, 2021 VS 2022 VS 2023
6.3 Global Key Players of Covid-19 Vaccine Head office and Area Served
6.4 Global Covid-19 Vaccine Players, Product Type & Application
6.5 Global Covid-19 Vaccine Players, Date of Enter into This Industry
6.6 Global Covid-19 Vaccine Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 NORTH AMERICA
7.1 North America Covid-19 Vaccine Market Size (2018-2029)
7.2 North America Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 North America Covid-19 Vaccine Market Size by Country (2018-2023)
7.4 North America Covid-19 Vaccine Market Size by Country (2024-2029)
7.5 United States
7.6 Canada
8 EUROPE
8.1 Europe Covid-19 Vaccine Market Size (2018-2029)
8.2 Europe Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
8.3 Europe Covid-19 Vaccine Market Size by Country (2018-2023)
8.4 Europe Covid-19 Vaccine Market Size by Country (2024-2029)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
9 ASIA-PACIFIC
9.1 Asia-Pacific Covid-19 Vaccine Market Size (2018-2029)
9.2 Asia-Pacific Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Asia-Pacific Covid-19 Vaccine Market Size by Country (2018-2023)
9.4 Asia-Pacific Covid-19 Vaccine Market Size by Country (2024-2029)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
10 LATIN AMERICA
10.1 Latin America Covid-19 Vaccine Market Size (2018-2029)
10.2 Latin America Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Latin America Covid-19 Vaccine Market Size by Country (2018-2023)
10.4 Latin America Covid-19 Vaccine Market Size by Country (2024-2029)
9.4 Mexico
9.5 Brazil
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Covid-19 Vaccine Market Size (2018-2029)
11.2 Middle East & Africa Covid-19 Vaccine Market Growth Rate by Country: 2018 VS 2022 VS 2029
11.3 Middle East & Africa Covid-19 Vaccine Market Size by Country (2018-2023)
11.4 Middle East & Africa Covid-19 Vaccine Market Size by Country (2024-2029)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
12 PLAYERS PROFILED
11.1 Moderna
11.1.1 Moderna Company Detail
11.1.2 Moderna Business Overview
11.1.3 Moderna Covid-19 Vaccine Introduction
11.1.4 Moderna Revenue in Covid-19 Vaccine Business (2017-2022)
11.1.5 Moderna Recent Development
11.2 CanSino Biologicals
11.2.1 CanSino Biologicals Company Detail
11.2.2 CanSino Biologicals Business Overview
11.2.3 CanSino Biologicals Covid-19 Vaccine Introduction
11.2.4 CanSino Biologicals Revenue in Covid-19 Vaccine Business (2017-2022)
11.2.5 CanSino Biologicals Recent Development
11.3 Inovio Pharmaceuticals
11.3.1 Inovio Pharmaceuticals Company Detail
11.3.2 Inovio Pharmaceuticals Business Overview
11.3.3 Inovio Pharmaceuticals Covid-19 Vaccine Introduction
11.3.4 Inovio Pharmaceuticals Revenue in Covid-19 Vaccine Business (2017-2022)
11.3.5 Inovio Pharmaceuticals Recent Development
11.4 Shenzhen Geno-Immune Medical Institute
11.4.1 Shenzhen Geno-Immune Medical Institute Company Detail
11.4.2 Shenzhen Geno-Immune Medical Institute Business Overview
11.4.3 Shenzhen Geno-Immune Medical Institute Covid-19 Vaccine Introduction
11.4.4 Shenzhen Geno-Immune Medical Institute Revenue in Covid-19 Vaccine Business (2017-2022)
11.4.5 Shenzhen Geno-Immune Medical Institute Recent Development
11.5 GlaxoSmithKine
11.5.1 GlaxoSmithKine Company Detail
11.5.2 GlaxoSmithKine Business Overview
11.5.3 GlaxoSmithKine Covid-19 Vaccine Introduction
11.5.4 GlaxoSmithKine Revenue in Covid-19 Vaccine Business (2017-2022)
11.5.5 GlaxoSmithKine Recent Development
11.6 Pfizer
11.6.1 Pfizer Company Detail
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Covid-19 Vaccine Introduction
11.6.4 Pfizer Revenue in Covid-19 Vaccine Business (2017-2022)
11.6.5 Pfizer Recent Development
11.7 Johnson?Johnson
11.7.1 Johnson?Johnson Company Detail
11.7.2 Johnson?Johnson Business Overview
11.7.3 Johnson?Johnson Covid-19 Vaccine Introduction
11.7.4 Johnson?Johnson Revenue in Covid-19 Vaccine Business (2017-2022)
11.7.5 Johnson?Johnson Recent Development
11.8 Heat Biologics
11.8.1 Heat Biologics Company Detail
11.8.2 Heat Biologics Business Overview
11.8.3 Heat Biologics Covid-19 Vaccine Introduction
11.8.4 Heat Biologics Revenue in Covid-19 Vaccine Business (2017-2022)
11.8.5 Heat Biologics Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Covid-19 Vaccine Introduction
11.9.4 Sanofi Revenue in Covid-19 Vaccine Business (2017-2022)
11.9.5 Sanofi Recent Development
13 REPORT CONCLUSION
14 DISCLAIMER
